← Scroll for more →
Financial Statements — IFBD
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.69 | 4.69 | 0.05 | 1.04 | 1.42 | 6.29 |
| Short-term Investments | -- | -- | -- | 6.70 | 6.66 | 7.09 |
| Accounts Receivable | 3.45 | 3.86 | 0.18 | 0.40 | 2.90 | 6.34 |
| Total Current Assets | 9.58 | 10.04 | 5.47 | 13.37 | 12.25 | 20.37 |
| Property, Plant & Equipment | 0.64 | 0.78 | -- | 0.15 | 0.18 | 0.25 |
| Goodwill | 12.56 | 62.44 | -- | 0.48 | 1.91 | 2.01 |
| Intangible Assets | 12.56 | -- | -- | 2.56 | 3.98 | 4.78 |
| Total Non-current Assets* | 13.57 | 63.73 | 52.19 | 3.26 | 6.43 | 8.11 |
| Total Assets | 23.15 | 73.78 | 57.66 | 16.63 | 18.68 | 28.48 |
| Accounts Payable | 3.32 | 2.79 | -- | 3.22 | 3.27 | 4.53 |
| Total Current Liabilities | 4.85 | 3.81 | 0.06 | 24.12 | 10.59 | 12.27 |
| Total Non-current Liabilities* | 0.10 | 3.16 | 0.00 | 0.03 | 0.12 | 0.31 |
| Total Liabilities | 4.95 | 6.98 | 0.06 | 24.15 | 10.71 | 12.58 |
| Retained Earnings | (78.78) | (26.70) | (24.60) | (28.07) | (20.55) | (12.80) |
| Total Stockholder Equity | 17.67 | 64.77 | 57.59 | 6.58 | 7.16 | 15.05 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2 2022 |
|---|---|
| Total Revenue | 2.58 |
| Cost of Revenue | 1.66 |
| Gross Profit | 0.92 |
| Research & Development | 2.39 |
| Selling, General & Admin | 3.32 |
| Total Operating Expenses | 8.15 |
| Operating Income | (7.23) |
| Interest Expense | 0.11 |
| Pretax Income | (7.83) |
| Tax Provision | 0.04 |
| Net Income | (7.75) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2022 |
|---|---|
| Operating Cash Flow | (3.99) |
| Investing Cash Flow | (13.61) |
| Financing Cash Flow | (0.73) |
← Scroll for more columns →